|
Home - ADARx Pharmaceuticals
Amplifying Science Leveraging our decades of siRNA drug development experience and proprietary technologies, we are focused on developing next-generation siR...
|
88 % |
|
Home | Neurocrine Biosciences
<p>Neurocrine Biosciences — dedicated to discovering and developing life-changing treatments for patients with neurological, psychiatric, and endocrine disor...
|
87 % |
|
Harnessing Breakthrough Science to Advance Hematology Care
Committed to turning scientific discoveries into effective medicines that will disrupt the current standard of care, alleviate suffering, and have a meaningf...
|
87 % |
|
Y-mAbs Therapeautics
|
87 % |
|
Keros Therapeutics - Powered by TGF-ß science, inspired by patients
Our mission is to innovate therapies that have the potential to shift the treatment of hematological,pulmonary and cardiovascular disorders
|
87 % |
|
Improving Patients' Lives | Jazz Pharmaceuticals
Jazz Pharmaceuticals is focused on improving patients’ lives by identifying, developing, and commercializing products that address unmet medical needs.
|
85 % |
|
MSD | Home
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
|
85 % |
|
Expanding access to essential medicines | Amneal Pharmaceuticals
Amneal is a U.S.-based biopharmaceutical company. We are expanding access to safe, effective and affordable medicines.
|
85 % |
|
GH Research
GH Research is a clinical-stage pharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
|
85 % |
|
Immuneering | Deep Cyclic Inhibitors for MAPK-Driven Cancers
Immuneering is developing Deep Cyclic Inhibitors to outpace cancer adaptation, improve durability, and preserve patient quality of life in MAPK-driven cancers.
|
85 % |
|
Leading Innovation in Psychiatric Treatment | Alto Neuroscience
We leverage the biology of individuals’ brains to develop personalized and highly effective medicines, helping patients get better faster.
|
85 % |
|
Enliven Therapeutics | Small Molecule Kinase Inhibitors
We are a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors to help patients with cancer live longer and...
|
85 % |
|
CG Oncology | Focused on the Future of Bladder Cancer
CG Oncology is a late-stage pharmaceutical company that is passionate about developing and delivering bladder-sparing immunotherapies.
|
85 % |
|
CG Oncology | Focused on the Future of Bladder Cancer
CG Oncology is a late-stage pharmaceutical company that is passionate about developing and delivering bladder-sparing immunotherapies.
|
85 % |
|
Genentech
Breakthrough science. One moment, one day, one person at a time.
|
84 % |
|
Haemonetics®
Haemonetics provides a suite of innovative medical technology solutions that improve the quality, effectiveness and efficiency of care. We challenge ourselve...
|
84 % |
|
Merck | Home
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
|
84 % |
|
ZYUS Life Sciences - Home
|
84 % |
|
Propanc Biopharma, Inc. (PPCB)
|
84 % |
|
Home - vTv Therapeutics
|
84 % |
Detected social media networks